ABOLIS
Latest round
- Series A
Last raised
- Aug 2024
Total raised
- $11M
Investors
- 6
About ABOLIS
Founded in 2014 and based in Evry, France, ABOLIS operates as a biotechnology company. The company was founded by its CEO, Cyrille Pauthenier, Valérie Brunel. ABOLIS specializes in providing industrial solutions using natural and modified microorganisms for various industries, including food, healthcare, cosmetics, and chemistry. The company develops and offers biosynthesis processes to transform microorganisms to produce complex molecular entities. The company uses microorganisms to produce small molecules, proteins, and microbiomes for a variety of applications.
Who invested in ABOLIS
6 investors across 1 round
See all investors in ABOLIS
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Aug 7, 2024
Amount
$11M
Investors
Questions about ABOLIS
Who invested in ABOLIS?
ABOLIS has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ABOLIS raised?
ABOLIS has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did ABOLIS last raise money?
ABOLIS's most recent round on record is a Series A, in Aug 2024.
What does ABOLIS do?
Founded in 2014 and based in Evry, France, ABOLIS operates as a biotechnology company.
Where is ABOLIS headquartered?
ABOLIS is headquartered in Evry, France.
Which VCs invest in companies like ABOLIS?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at ABOLIS's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like ABOLIS? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.